Diverting ileostomy is a risk factor for renal impairment during CAPOX therapy
Authors:
- 22 July 2022
- journal article
- research article
- Published by Springer Nature in International Journal of Clinical Oncology
- Vol. 27 (10) , 1616-1623
Abstract
Purpose Temporary ileostomy is sometimes created after colorectal surgery and may cause renal impairment. However, the impact of ileostomy on renal function during adjuvant chemotherapy for colorectal cancer (CRC) remains unknown. The aim of the present study was to examine the effects of ileostomy on renal function during adjuvant chemotherapy. Methods We examined 184 patients who received adjuvant CAPOX therapy (capecitabine and oxaliplatin) for CRC with or without ileostomy between January 2011 and December 2020 at the University of Tokyo Hospital. Clinicopathological factors, including renal function, were retrospectively reviewed in association with temporary ileostomy. Factors associated with reductions in the estimated glomerular filtration rate (eGFR) during CAPOX therapy were analyzed. Results Eighteen patients (10%) underwent temporary ileostomy. The maximum decrease in eGFR during CAPOX therapy was significantly higher in patients with than in those without ileostomy (− 16.1 vs. − 5.6 mL/min/1.73m2, p = 0.003). A multivariate analysis identified ileostomy as one of factors independently associated with reductions in eGFR during CAPOX therapy (p = 0.003). The cumulative number of readmission due to dehydration was also higher in patients with ileostomy (33% vs. 1%, p < 0.001). Conclusions Ileostomy significantly reduced eGFR during adjuvant CAPOX therapy. Therefore, renal function needs to be monitored during CAPOX therapy, particularly in patients with ileostomy.Keywords
All Related Versions
This publication has 35 references indexed in Scilit:
- Consequences of Anastomotic Leak After Restorative Proctectomy for CancerDiseases of the Colon & Rectum, 2013
- Dehydration Is the Most Common Indication for Readmission After Diverting Ileostomy CreationDiseases of the Colon & Rectum, 2012
- Increased Local Recurrence and Reduced Survival From Colorectal Cancer Following Anastomotic LeakAnnals of Surgery, 2011
- Stoma complications: a literature overviewColorectal Disease, 2009
- Revised Equations for Estimated GFR From Serum Creatinine in JapanAmerican Journal of Kidney Diseases, 2009
- Phase III Trial of Capecitabine Plus Oxaliplatin As Adjuvant Therapy for Stage III Colon Cancer: A Planned Safety Analysis in 1,864 PatientsJournal of Clinical Oncology, 2007
- Risk Factors for Anastomotic Leakage after Surgery for Colorectal Cancer: Results of Prospective SurveillanceJournal of the American College of Surgeons, 2006
- Fluorouracil plus Levamisole as Effective Adjuvant Therapy after Resection of Stage III Colon Carcinoma: A Final ReportAnnals of Internal Medicine, 1995
- Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon CarcinomaNew England Journal of Medicine, 1990
- Complications of loop ileostomyThe American Journal of Surgery, 1987